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Abstract Advances in catheter-based interventions in
structural and congenital heart disease have mandated an
increased demand for three-dimensional (3D) visualisation
of complex cardiac anatomy. Despite progress in 3D imag-
ing modalities, the pre- and periprocedural visualisation of
spatial anatomy is relegated to two-dimensional flat screen
representations. 3D printing is an evolving technology
based on the concept of additive manufacturing, where
computerised digital surface renders are converted into
physical models. Printed models replicate complex struc-
tures in tangible forms that cardiovascular physicians and
surgeons can use for education, preprocedural planning and
device testing. In this review we discuss the different steps
of the 3D printing process, which include image acquisi-
tion, segmentation, printing methods and materials. We
also examine the expanded applications of 3D printing in
the catheter-based treatment of adult patients with structural
and congenital heart disease while highlighting the current
limitations of this technology in terms of segmentation,
model accuracy and dynamic capabilities. Furthermore, we
provide information on the resources needed to establish
a hospital-based 3D printing laboratory.
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Introduction
Structural heart disease intervention has been a rapidly
growing field in interventional cardiology, involving a broad-
ening variety of catheter-based treatment options for ac-
quired and congenital heart defects. Transcatheter inter-
ventions have become the standard of care for several
structural and functional abnormalities of heart valves,
cardiac chambers and proximal vessels [1]. Patients with
congenital heart defects and complex previous operations
represent a challenge due to a wide variation in mor-
phology and complex cardiac anatomy. Despite currently
available three-dimensional (3D) imaging modalities most
procedures are still planned using images viewed on two-
dimensional (2D) screens. The 2D representation makes
it inherently more difficult to fully appreciate the complex
3D relationships of cardiac structures relevant to particular
interventions. 3D printing (also referred to as rapid pro-
totyping, stereolithography or additive manufacturing) is
a technology which fabricates a physical model from a 3D
computerised imaging source file. The first medical appli-
cation was used to produce surgical implants for oral and
maxillofacial surgery [2] and prosthetics for orthopaedic
surgery [3]. The ability to generate a tangible 3D model of
complex cardiac anatomy has made this a promising tool
for education, preprocedural planning, and device testing in
structural and congenital heart disease interventions (Fig. 1;
[4–6]). However, due to the expertise required to generate
3D models and the investment of resources involved the es-
tablishment of 3D printing labs has mostly been limited to
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Fig. 1 3D printing workflow
and applications KEY MESSAGE
  
-  3D printing is a process by which source image data (CT, MRI or echocardiography) can be post-
    processed, converted into a stereolithographic file and allow physical models to be printed. 
-  The crucial step in the 3D printing workflow is image segmentation where regions of anatomical 
    interest are extracted 
-  In structural and congenital heart disease interventions, 3D printing models are used for the 
    purpose of education, preprocedural planning and device testing.
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larger teaching hospitals and research centres. This review
will discuss a 3D printing workflow, review the expanded
applications of 3D printing in the catheter-based treatment
of adults with structural and congenital heart disease and
will outline the resources needed to establish a hospital-
based 3D printing laboratory.
3D printing step-by-step
The availability of cross-sectional cardiac imaging, such as
magnetic resonance imaging (MRI) or computed tomog-
raphy (CT), for most patients with complex cardiovascu-
lar disease is favourable for the application of 3D recon-
struction and printing. 3D echocardiography is also readily
available in many clinical settings. Commonly available
post-processing software allows anatomic visualisation via
3D renderings, but these renders cannot be directly printed.
Special software is required to process the source imaging
datasets to generate a model via segmentation and export it
as a stereolithographic (STL) file to be printed (Fig. 1).
Image acquisition
The three most commonly used medical imaging modalities
for 3D image generation are CT, MRI and echocardiogra-
phy. Spatial resolution, tissue contrast and slice thickness
determine the quality of the 3D dataset and are a prereq-
uisite for 3D printing. CT and MRI are the most common
sources of datasets for 3D printing because of their ability
to image the entire heart with detailed intracardiac anatomy.
Echocardiography has a superior ability to image fast mov-
ing structures such as cardiac valves [7]. Fusion of different
modalities (e. g. ventricles from CT, valves from echocar-
diography) to create a single 3D model has been reported
[8]. Both ECG and non-ECG gated MRI have been used for
3D modelling and both seem to provide 3D printed mod-
els of comparable quality. Optimal CT images should be
contrast enhanced, multiphase ECG-gated acquired during
breath-hold [6]. Isotropic volumetric data should be recon-
structed with a slice thickness between 0.5–1.25 mm to ease
segmentation and generate accurate 3D printing models [9].
In echocardiography, conversion to a ‘Cartesian’ DICOM
file is necessary for 3D model generation and this requires
special proprietary software (e. g. Philips QLAB, Philips
Healthcare, USA).
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Image segmentation
Segmentation is part of the post-processing sequence
wherein source images are partitioned into multiple simple
geometrical elements of known coordinates in 3D space.
It is achieved using complex techniques such as surface
triangulation, isosurfacing and volume rendering.
There is no standardised approach to image segmenta-
tion. Several manual, semi-automatic and automatic image
segmentation methods have been used. The most common
are: region growing and brightness thresholding followed
by manual editing [7]. Region growing examines the re-
lationship of neighbouring pixels to an initial seed point
and determines whether the neighbouring pixels should be
added as part of that region (Fig. 2a, b). Thresholding is
a method where pixels are partitioned depending on their
intensity or brightness value (Fig. 2c, d). Manual editing
is necessary to correct segmentations errors (exclusion of
artefacts and/or filling of dropout gaps), surface smoothing,
colouring and 3D model cropping. Commercially avail-
able software (Mimics, Belgium) combines semi-automatic
segmentation and manual editing in a single product and al-
lows segmentation from all imaging modalities. Freeware,
Fig. 2 Image segmentation process. a,b Screenshot from ITK-SNAP-Software (http://www.itksnap.org) Region growing as part of segmentation.
a Example of segmentation via region growth (aorta). Select the region of interest for semi-automatic active contour segmentation and laying down
the red dots to define where the region of interest is. b Activating the algorithm causes the dots to expand into the region of interest. c Screenshot
from Mimics-Software as an example of thresholding and manual editing. d The histogram window on the bottom right-hand corner is the graph
where thresholding is usually set
such as ITK-SNAP or 3D Slicer [10, 11], is also available
but is less user friendly and currently limited to CT and
MRI data. The process is time consuming, requires exper-
tise with specific segmentation software as well as under-
standing of the patient’s complex structural and congenital
anatomy. Throughout each step, there is a risk of introduc-
ing design errors and manipulating the original source data
in order to generate oversimplified 3D models [12].
3D printing
There are three common types of 3D printers used for
medical printing. They are as defined by the mechanics
and materials used to generate a model: fused deposition
modelling (FDM), stereolithography (SLA) and PolyJet 3D
printers. These, and other types of 3D printers, are briefly
summarised in Table 1.
FDM printers utilise thermo-plastic filaments and
a layer-by-layer technique. The filaments are rapidly
heated to liquefy the plastic into a semi-molten state and
then extruded in a very thin layer onto a heated surface
[13]. Once extruded, the plastic quickly solidifies and fuses
with the underlying adjacent layer. FDM 3D printers are
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Table 1 Summary of 3D printer technologies
3D printer technology Type of materials used Strengths Limitations
Fused Deposition Modelling
(FDM)
Thermoplastics Low cost, easy to operate, wide
variety of usable thermoplastic
materials for printing
Relatively long print times,
print resolution low compared
with other types of printers
(0.1–1.2 mm)
Stereolithography (SLA) Photosensitive resins Can be low cost, high resolution
(0.025–0.1 mm), excellent print
surface quality
Relatively long print times, ex-
tensive post-processing required,




Photosensitive resins Extremely fast print speeds, high
resolution prints
Printers cannot be purchased, but
may be leased on a year-to-year
basis
PolyJet Photosensitive resins Extremely high resolution (16 mi-
crons), multi-durometer printing,
multi-coloured printing, large build
volume
Expensive to purchase and oper-
ate, printed objects are relatively
brittle
Selective Laser Sintering (SLS) Chamber of powdered mate-
rial including nylons, glass,
ceramics and metal
Very large build volumes can pro-
duce mechanically functional prints
out of ceramics and metals, excel-
lent surface quality and precision
Expensive to purchase and op-
erate, difficult to operate and
calibrate
capable of producing layers between 0.1 and 1.2 mm thick.
A growing variety of stiff and elastomeric thermoplastics
have recently become available. Desktop FDM 3D printers
typically cost a few thousand US dollars and the thermo-
plastic filaments range from 20 to 100 US dollars per kg,
making fabrication costs relatively affordable.
SLA printers utilise a photosensitive resin and ultravi-
olet light. The ultraviolet light traces the geometry of an
object into a resin bath causing photo-polymerisation of the
resin into a solid [13]. Desktop SLA 3D printers are avail-
able and priced similarly to FDM systems with a slightly
higher production cost. SLA printers provide extremely
high resolution ranging from 0.025 to 0.1 mm with excel-
lent surface finish after considerable post-processing [13].
The main drawbacks of desktop SLA printers are the rela-
tively small build volumes and long build times required to
cure the photosensitive resins into 3D models. However, re-
cent advances in printers utilising similar technology, such
as Continuous Liquid Interface Production (CLIP), has dra-
matically reduced print times [14].
PolyJet printers utilise a photo curable resin sprayed in
a very fine layer and then cured into a solid via ultraviolet
light [13, 14]. PolyJet printers allow extremely high reso-
lution of 16 microns and the ability to produce regions of
variable durometer within a single 3D printed object. Fur-
thermore, objects can be produced with a wide spectrum of
colour within the same print. These printers are in the order
of hundreds of thousands of US dollars and have a relatively
high production cost.
Applications of 3D printing
Due to its ability to illustrate complex anatomy of cardio-
vascular structures and cavities, 3D printing is rapidly gain-
ing interest in interventional cardiology and cardiovascular
surgery [5]. Over the past 5 years there has been a remark-
able increase in published studies and case reports for ap-
plications of 3D printing in structural and congenital heart
disease interventions gap (Table 2 and 3). The applica-
tions of 3D printing vary from anatomical education and
training, to preprocedural planning, simulation and device
testing [15].
Education and training
Conceptual 3D understanding of complex cardiac struc-
tures remains a main challenge for cardiologists and ra-
diologists and it is traditionally taught using 2D images
or pathological specimens. 3D printing allows the devel-
opment of accurate life-like educational tools (Fig. 3) to
illustrate complex cardiovascular anatomy and pathology.
In terms of qualitative assessment of knowledge reporting,
knowledge acquisition and structural conceptualisation, 3D
printed models have been shown to improve physicians’
understanding of congenital heart disease compared with
regular imaging modalities [15]. Patient-specific 3D print-
ing models have the potential to enhance engagement with
patients and improve communication between the cardiol-
ogist and the patient’s family. Better understanding may
also impact a patient’s psychological adaptation following
treatment [4].
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Fig. 3 3D printing models for
educational purposes. a,b SLA
transparent full heart model
demonstrating normal anatomy.
c,d FDM models illustrating
standard transthoracic echocar-
diographic 2D views (c apical
four chamber view; d parasternal
long axis)
Structural and valvular heart disease interventions
In structural heart disease interventions, the vast majority
of 3D printed models have been used to assist planning
and simulating complex interventions (Table 2), especially
when common 2D or 3D imaging modalities raise uncer-
tainties in terms of access relationships, or location of de-
fects or certain structures.
Chaowu et al. reported a successful in vitro trial occlu-
sion of an atrial septal defect (ASD) with rim deficiency on
the basis of a personalised 3D printed heart model. It has
shown to be a feasible method to identify the appropriate
candidates, especially for large ASDs with rim deficiency,
and thus decreases related complications [16]. 3D printed
models have shown to be beneficial in preprocedural plan-
ning and device testing of other transcatheter interventions
such as left atrial appendages occlusions [17] and interven-
tions on the ascending aorta [18].
Fig. 4 FDM/PLA – 3D
printing model of an inferior
post-myocardial infarction VSD
with aneurysm. Amplatzer
device crossing the VSD from
the venous, right ventricular
side. a right ventricular view.
b left ventricular view
Case example (Fig. 4)
Referring to other reports, at our centre we have success-
fully closed a post-inferior myocardial infarction ventricu-
lar septal defect (VSD) with a post-infarct VSD occluder
device based on a CT-derived 3D printed model. A 63-
year-old woman with a subacute post-infarct VSD and re-
lated pulmonary hypertension and was considered for trans-
catheter closure. The CT revealed a large defect in the
basal to mid inferior septum which measured approximately
31 × 32 × 23 mm en face. We questioned the precision of
these measurements and produced a polylactic acid (PLA)
FDM 3D printed model of the patient’s septum and inferior
VSD. On preprocedural angiography and transoesophageal
echocardiography (TEE) the maximal diameter of the VSD
was between 11 and 13 mm and was consistent with the
measurements and morphology of the 3D printed model.
We were able to successfully deliver an 18 mm Amplatzer
70 Neth Heart J (2017) 25:65–75
Table 2 Overview on literature on 3D printing applications for transcatheter interventions in structural and valvular heart disease
Topic Application of 3D printing models Benefit
Acquired structural heart disease
Coronary interventions Coronary 3D models for percutaneous inter-
vention (PCI) optimisation strategies [33, 34]
– In vitro simulation of PCI in complex coronary anatomy
– In vitro stent placement and hydrofluid testing of haemo-
dynamics and stent positioning
– Virtual modelling of fractional flow reserve (FFR) and
hyperaemic stenosis resistance index
Left atrial appendage (LAA) 3D printing models for planning/simulating
LAA occlusion procedures [35, 36]
– LAA 3D models effectively guide device selection and
placement of the LAA occlusion device
– Optimising transseptal puncture in LAA occlusion
Great vessels Interventions of ascending aorta:
– Custom-made devices for coil embolisa-
tion of an anastomotic leak after aortic arch
replacement [18]
– Occlusion of an ascending aortic pseudo
aneurysm [37]
– Choosing the treatment option, planning and simulating
the occlusion of the pseudoaneurysm
– 3D models are used to build the custom-made occluder
device
Preprocedural planning/simulating trans-
catheter caval valve implantation [38]
– 3D printing of the right atrial-inferior caval vein
(RA-IVC) topography aids in transcatheter valve se-
lection
Valvular heart disease
Aortic valve Preprocedural planning/simulating trans-
catheter aortic valve implantations (TAVI)
[21, 39]
– Calcium distribution patterns of the aortic
valve as a risk factor for the need of perma-
nent pacemaker implantation [40]
– 3D printing of aortic roots to design tailored
transcatheter stented aortic valves [41, 42]
– Patient-specific 3D models to assess the physical inter-
play of the aortic root and implanted valves.
– 3D models may complement traditional techniques used
for predicting which patients are more likely to develop
paravalvular aortic regurgitation
– 3D printed tissue-mimicking aortic root may enable
predictions of post-TAVI root strain and distribution and
aortic flow pattern
Replicating patient-specific severe aortic valve
stenosis with functional 3D modelling [22]
– Using fused dual-material 3D printing and an in vitro
pulsatile flow loop demonstrates that patient-specific
models can replicate both the anatomic and functional
properties of severe degenerative aortic valve stenosis
Mitral valve Preprocedural planning/simulating trans-
catheter mitral valve interventions [19, 23]
– Preprocedural evaluation of catheter-based repair devices
within specific patient 3D printed valve geometry
– Integration of CT and 3D print could assist in predicting
left ventricular outflow tract obstruction
– 3D models of normal and pathological mitral valve an-
nuli before and after repair procedures
Tricuspid valve Planning of percutaneous tricuspid interven-
tions [43]
– 3D printing is helpful clinical tool for planning and
training operators in the early stage of this innovative
intervention
– Measuring valvular diameters on 3D models is feasible
and compared with measurements of 2D imaging and
models, indicating accuracy of <1 mm
Pulmonary valve See congenital heart disease (Table 2)
(St. Jude Medical Inc., USA) post-infarct VSD device
(Fig. 4).
Valvular interventions
Cardiac valves are fast moving structures that are best
imaged using 3D echocardiography. One exception is
severely calcified, relatively immobile aortic valves and
roots that have been successfully reconstructed using CT
data. Echocardiography has been used to print accurate
rigid 3D models of the mitral valve and ring [19]. A flex-
ible mitral valve has also been created on a 3D printed
mould and tested in a pulse replicator [20].
Combined-material 3D printed aortic valve and root has
been reported to mimic calcified regions and become an
accurate tool for preprocedural testing of transcatheter aor-
tic valve implantation and predict paravalvular regurgitation
[21]. 3D printed models also seem to replicate the anatomic
and functional properties of severe degenerative aortic valve
stenosis in in-vitro flow systems [22]. 3D printing of cell
scaffoldings is in the very early testing phase for the aor-
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Fig. 5 Surgical repair of
a supra-cardiac total anoma-
lous pulmonary venous con-
nection with redirection of the
pulmonary veins to a conflu-
ence prior to connection to the
left atrium. Haemodynami-
cally relevant stenosis between
confluence and the left atrium.
a,b FDM 3D printed model
showing anatomy of the pul-
monary venous (PV) confluence
and the left atrium (LA), ante-
rior (a) and posterior (b) view.
c,d Periprocedural angiography.
c Draining PV confluence and
stenosis, (d) relief of stenosis
post stenting. e,f Periprocedu-
ral TEE. 2D and colour flow
Doppler showing relevant steno-
sis between PV confluence
and LA with relevant proximal
isovelocity surface area (PISA)
before dilatation and stenting (e)
and no relevant stenosis post
stenting (f)
tic root, and has the potential for personalised implantable
device fabrication and valve tissue engineering [18, 23].
Congenital heart disease interventions
Despite current classifications and treatment guidelines [24,
25] for adults with congenital heart disease, most of the
management options are customised to individual patient
anatomic variations, more so than with acquired disease.
This makes patient-specific 3D printed models an ideal tool
in this subset of patients for the planning of catheter-based
(Table 3) and surgical interventions [4, 5, 8, 15].
Poterucha et al. reported the use of 3D right ventricu-
lar outflow tract printing and 3D rotational angiography to
guide pulmonary valve stenting and valve implantation [26].
Hybrid 3D printed heart models of congenitally corrected
transposition of the great arteries (TGA) [8] and dextroTGA
after a Mustard operation [27] have been produced for illus-
trating the volume and morphologies of the chambers and
proximal vessels. For those patients, 3D models could pro-
vide important insights into the changes in size and shape of
the different chambers and the anatomy of vessels entering
and exiting the baffles to the related ventricle.
In the future 3D printed vascular grafts for patients with
congenital heart disease could be biodegradable, mechan-
ically compatible with vascular tissues, and support neo-
tissue formation and growth [28].
Case example (Fig. 5)
A 64-year-old patient with a history of surgical repair of
supra-cardiac total anomalous pulmonary venous return
with redirection of the pulmonary veins to a confluence
prior to connection to the left atrium was admitted due to
progressive dyspnoea on exertion. MRI and TEE showed
a haemodynamically relevant stenosis between this conflu-
ence and the left atrium which led to pulmonary hyperten-
sion. Consensus was to proceed with balloon dilatation and
stenting of the narrowed connection to the left atrium.
As seen in Fig. 5, the patient specific 3D printed model
was especially helpful in periprocedural planning. It helped
to visualise the spatial orientation of the pulmonary ve-
nous confluence, the orifice and its relation to the left
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Table 3 Overview on literature on 3D printing applications for education and transcatheter interventions in congenital heart disease
Topic Application of 3D printing models Benefit
Congenital heart disease
Complex congenital anatomy Physician education and understanding of
complex anatomy [15, 44]
– Effective educational tool for physicians to improve
understanding of congenital cardiac anatomy
– Subjective improvement of understanding of congeni-
tal heart disease with 3D printing models compared to
regular 2D/3D imaging modalities (e. g. CT/MRI)
Patient-specific 3D printing models for
patient education and communication [4]
– Patient-specific models can enhance engagement with
parents and improve communication between cardiolo-
gists and patient/parents
Deriving 3D printing models from echocar-
diography and combined imaging modali-
ties [8, 26, 45]
– Feasibility of deriving 3D printing from ultrasound pro-
vides an additional cost-effective and patient-centred
option
– Integration of the strengths of two or more imaging
modalities into 3D printing is feasible and has the poten-
tial to enhance visualisation of cardiac pathomorphology
Atrial septal defect (ASD) Preprocedural planning/simulating of trans-
catheter ASD closure:
– secundum ASD with rim deficiency [16]
– inferior vena cava type ASD with patent
ductus arteriosus occlusion device [46]
– 3D printing models allowed to overcome the 3D visu-
alisation of the ASD and guides device selection and
placement
Ventricular septal defect (VSD) – Preprocedural planning of transcatheter
VSD closure for postinfarct or complex
muscular VSDs [47, 48]
– Utilising 3D printing model to visualise location and
size of VSD as well as trabeculations, papillary muscle
bundles to guide size and type of septal occluder
Aortic coarctation Planning/simulating endovascular stenting
in transverse aortic arch hypoplasia [49]
– 3D printing models accurately replicate patients’
anatomy and are helpful in planning endovascular stent-
ing in transverse arch hypoplasia
Transposition of the great arter-
ies (TGA)
Hybrid 3D printing with congenitally cor-
rected transposition of the great arteries
(ccTGA) [8]
Patient-specific 3D models of the cardiac
chambers of a patient with D-TGA after the
Mustard operation [27]
– 3D models give important insights into the changes in
size and shape of the different chambers and the patterns
of blood flow from the pulmonary and systemic veins to
the “appropriate” ventricle.
– Helpful in understanding and optimising the overall
haemodynamic function after the Mustard operation
atrium. After a transseptal puncture we successfully per-
formed a balloon dilatation and a subsequent stenting of the
narrowed confluence orifice (Genesis 3910B stent mounted
on a 14 mm, Z-Med II balloon) into the confluence.
Establishing an in-hospital 3D printing laboratory
Establishing a 3D printing laboratory requires planning in
three main categories: hardware, software and personnel.
The necessary hardware includes: computer workstations,
secured data storage, connectivity to the hospital imaging
network and 3D printers. As previously described, the price
of printers varies from a few thousands for desktop FDMs
to a million US dollars for an industrial SLA. The follow-
ing factors help guiding the choice of 3D printer: 3D print
volume, turnaround time, type and need to merge of multi-
ple materials. The costs of maintenance, printing materials
and development cycle of new technologies have to be con-
sidered in this planning stage. Low cost desktop printers
have significantly improved their performance over the past
few years and allow affordable prototyping, making them
ideal throughout the learning phase of segmentation and
printing. Outsourcing single, more complex, prints should
be considered as well as acquiring printers in stages as the
applications and workload demand.
A range of free, open-source software packages can be
part of the processes of segmentation, model editing, de
novo modelling and slicing for 3D printing. These in-
clude software which runs effectively on modern laptops
and desktops in Windows and Mac OS environments. 3D
Slicer [11] and ITK-SNAP [10, 29] are typically used for
segmentation and Meshmixer (Autodesk Inc., USA) for
model editing. Slicing for 3D printing can be performed
with a variety of software such as Slic3r (GNU Affero
General Public License, version 3) or PreForm software
(Formlabs, USA) depending on the printer being used. De
novo modelling and computer-aided design work can be
performed with tools such as Blender [30] and FreeCAD
[31]. Mimics segmentation software (Materialise, Belgium)
allows semi-automated segmentation and 3D modelling on
echocardiographic datasets. Mimics is proprietary and has
a yearly licensing fee.
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Lab staffing depends upon the workload, the complexity
and type of the models generated and the imaging modality
used. As an example, CT-based 3D model of bony struc-
tures are far less time consuming than echo-based models.
A biomedical industrial designer who is trained in perform-
ing 3D segmentations would be the ideal key player in the
lab but will need to work in direct contact with an imaging
or clinical medical specialist to guarantee the accuracy of
the end products.
Limitations and challenges
Several limitations exist with current 3D printing technolo-
gies. First, 3D printed objects are limited in replicating the
dynamic properties of the organs which they seek to repli-
cate [32]. While PolyJet printing technology can produce
objects with regions of varying properties, full replication
of the mechanical properties of cardiac tissue and its com-
plex, anisotropic structure has yet to be achieved. Secondly,
current image segmentation software requires a great deal
of non-automated human input to produce a 3D model ca-
pable of being printed. This has a major impact on resource
utilisation, as it requires dedicated trained personnel who
are difficult to justify at the moment for current experi-
mental clinical application. Additionally, this process is
time consuming and is prone to human operator error and
bias. This raises the issue of consistency in model accuracy.
Similarly, the time required to print even a small isolated
portion of the heart is in the order of at least one hour
with most available printers which limits the viability of
3D printing for urgent cases. Therefore cost-effectiveness,
model accuracy and clinical impact require more research
and scientific data.
Lastly, visualising complex intracardiac lesions or guid-
ing devices while simulating procedures sometimes requires
the printed models to be pellucid or have static cut planes
depending on the viewing angle. These can lead to time
consuming reproduction of different 3D printing models
for the same lesion and thus getting away from its original
purpose of a comprehensive model.
Emerging virtual reality 3D imaging technologies such
as Echopixel (EchoPixel, Inc., USA) or Real View Medi-
cal Holography (RealView Imaging Ltd., Israel) could be
complementary tools to address those limitations. Whereas
the segmentation process of the acquired images mainly re-
mains the same for 3D printing and 3D virtual imaging, the
STL files of the virtual 3D models can easily be uploaded
into these virtual reality 3D tools to optimise illustration
and the viewing angle of lesions by adding cutting planes.
However, the tangible aspect and mimicking of tissue be-
haviour can only be assessed with a physical model.
Conclusion
3D printing is a very powerful tool in structural and con-
genital heart disease interventions. It overcomes some of
the limitations of conventional 2D/3D imaging methods by
providing a tangible, physical 3D model of complex car-
diovascular structures. 3D models have shown promising
results in widespread applications from education to pro-
cedural planning and device testing. However, most of
the current literature is based on feasibility studies and
subjective qualitative comparisons with traditional imaging
modalities. The role of 3D printing models in day-to-day
clinical care as it pertains to morbidity and mortality is yet
to be determined. More work is finally needed to automate
and standardise the image segmentation process to decrease
costs of personnel and allow reproducible findings. Lastly,
evolving visualisation software solutions that can generate
holographic 3D models, therefore acting as “virtual” 3D
prints, are highly complementary to 3D printing especially
because they allow dynamic rendering and cutting planes
to optimise viewing angles.
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